Area of research
Pharmacology · Biological Psychiatry
Research interest
Research interests include Major depressive disorder, Antidepressant, Depression (economics), Internal medicine, Medicine, and Psychology.
Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response
Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial
Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder
Early onset of depression and treatment outcome in patients with major depressive disorder
Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years
Retinoic acid‐loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice
Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder
Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response
Teaching Conflicts of Interest and Shared Decision-Making to Improve Risk Communication: a Randomized Controlled Trial
Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment‐resistant depression
Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder
BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response
Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder
Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder
Clinical Predictors of Response to Magnetic Seizure Therapy in Depression
Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis
Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura
Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study
A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders
Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial
The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode
A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects
Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression